Ruxolitinib for Refractory Macrophage Activation Syndrome Complicating Adult-Onset Still’s Disease

• Ofer Levy,
• Arie Apel ,
• Hossam Alhdor,
• Avraham Mizrachi ,
• Nancy Agmon-Levin,
• Maya Koren-Michowitz ,
• Mirit Amit-Vazina

Affiliations

Ofer Levy

Shamir Medical Center, Internal Medicine B, Rheumatology Unit, Zerifin, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Arie Apel

Shamir Medical Center, Department of Hematology, Zerifin, Israel

Hossam Alhdor

Shamir Medical Center, Internal Medicine B, Zerifin, Israel

Avraham Mizrachi

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Shamir Medical Center, Internal Medicine B, Zerifin, Israel

Nancy Agmon-Levin

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Sheba Medical Center, Center for Autoimmune Diseases, Clinical Immunology, Angioedema and Allergy Unit, Tel-Hashomer, Israel

Maya Koren-Michowitz

Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Shamir Medical Center, Department of Hematology, Zerifin, Israel

Mirit Amit-Vazina

Shamir Medical Center, Internal Medicine B, Rheumatology Unit, Zerifin, Israel; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel